tiprankstipranks
Sumitomo Chemical India Ltd. (IN:SUMICHEM)
:SUMICHEM
India Market

Sumitomo Chemical India Ltd. (SUMICHEM) AI Stock Analysis

Compare
3 Followers

Top Page

IN:SUMICHEM

Sumitomo Chemical India Ltd.

(SUMICHEM)

Select Model
Select Model
Select Model
Neutral 61 (OpenAI - 5.2)
Rating:61Neutral
Price Target:
₹408.00
▼(-12.94% Downside)
Action:ReiteratedDate:11/19/25
Sumitomo Chemical India Ltd. demonstrates strong financial performance, which is the primary driver of its stock score. However, technical analysis indicates bearish momentum, and valuation metrics suggest the stock may be overvalued. These factors contribute to a moderate overall stock score.
Positive Factors
Healthy Profitability & Margins
Sustained gross margin >30% and net margin >16% indicate structural pricing power and efficient operations in formulated crop protection. Durable margins support reinvestment, cover R&D and regulatory costs, and provide buffer versus input cost volatility common in agrochemicals.
Negative Factors
Modest Revenue Growth
Low single-digit revenue growth suggests limited top-line dynamism relative to peers or constrained market expansion. Persistently sluggish growth can cap scalability, reduce operating leverage benefits, and force reliance on margin expansion or cost cuts to lift returns over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Healthy Profitability & Margins
Sustained gross margin >30% and net margin >16% indicate structural pricing power and efficient operations in formulated crop protection. Durable margins support reinvestment, cover R&D and regulatory costs, and provide buffer versus input cost volatility common in agrochemicals.
Read all positive factors

Sumitomo Chemical India Ltd. (SUMICHEM) vs. iShares MSCI India ETF (INDA)

Sumitomo Chemical India Ltd. Business Overview & Revenue Model

Company Description
Sumitomo Chemical India Limited engages in the manufacture and sale of household and public health insecticides, agricultural pesticides, and animal nutrition products in India and internationally. It operates through two segments, Agro Chemicals ...
How the Company Makes Money
SUMICHEM makes money primarily by selling agrochemical products used in crop protection. Its core revenue stream comes from the sale of formulated crop protection products (e.g., insecticides, herbicides, fungicides) to customers in India and in o...

Sumitomo Chemical India Ltd. Financial Statement Overview

Summary
Sumitomo Chemical India Ltd. exhibits strong financial health with consistent revenue growth and healthy profit margins. The balance sheet is solid with low leverage, and cash flows are strong, indicating effective cash management. However, there is room for improvement in cost management and shareholder returns.
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
82
Very Positive
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue33.08B31.49B28.44B35.11B30.61B26.45B
Gross Profit12.40B12.70B10.49B12.24B11.36B9.74B
EBITDA6.83B6.10B4.53B6.47B5.82B4.74B
Net Income5.43B5.05B3.70B5.02B4.24B3.45B
Balance Sheet
Total Assets44.39B39.64B33.13B33.69B30.10B26.70B
Cash, Cash Equivalents and Short-Term Investments11.33B12.59B8.91B5.63B5.75B5.32B
Total Debt582.48M518.93M302.49M339.72M375.84M326.35M
Total Liabilities12.37B10.59B8.69B9.87B10.82B11.29B
Stockholders Equity31.97B29.01B24.42B23.82B19.27B15.41B
Cash Flow
Free Cash Flow4.20B4.87B6.93B2.70B1.08B3.82B
Operating Cash Flow4.35B5.17B7.57B3.89B2.22B4.25B
Investing Cash Flow-3.60B-4.57B-4.20B-3.27B-2.90B-2.58B
Financing Cash Flow-726.93M-679.20M-3.37B-725.45M-626.38M-470.64M

Sumitomo Chemical India Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price468.65
Price Trends
50DMA
406.90
Negative
100DMA
435.58
Negative
200DMA
494.89
Negative
Market Momentum
MACD
-8.06
Negative
RSI
44.05
Neutral
STOCH
14.47
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SUMICHEM, the sentiment is Negative. The current price of 468.65 is above the 20-day moving average (MA) of 390.38, above the 50-day MA of 406.90, and below the 200-day MA of 494.89, indicating a bearish trend. The MACD of -8.06 indicates Negative momentum. The RSI at 44.05 is Neutral, neither overbought nor oversold. The STOCH value of 14.47 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:SUMICHEM.

Sumitomo Chemical India Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
₹58.62B12.103.68%-7.53%42.74%
68
Neutral
₹232.97B31.760.12%-2.24%31.43%
63
Neutral
₹45.93B700.000.92%0.91%18.12%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
61
Neutral
₹193.07B77.710.26%8.69%12.26%
60
Neutral
₹202.35B53.521.57%8.92%5.06%
59
Neutral
₹146.85B40.150.51%0.43%-42.29%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:SUMICHEM
Sumitomo Chemical India Ltd.
386.80
-141.42
-26.77%
IN:BASF
BASF India Limited
3,392.50
-1,056.53
-23.75%
IN:BAYERCROP
Bayer Cropscience India Limited
4,502.50
-95.44
-2.08%
IN:GNFC
Gujarat Narmada Valley Fertilizers & Chemicals Ltd.
398.95
-88.66
-18.18%
IN:HSCL
Himadri Speciality Chemical Ltd.
461.75
32.64
7.61%
IN:RALLIS
Rallis India Limited
236.20
18.80
8.65%

Sumitomo Chemical India Ltd. Corporate Events

Sumitomo Chemical India Unveils Investor Presentation for December 2025 Results
Jan 27, 2026
Sumitomo Chemical India Ltd. has released an investor presentation detailing its financial results for the quarter and nine months ended 31 December 2025, describing the period as “a year of resurgence.” The disclosure, made in line wi...
Sumitomo Chemical India Releases Unaudited Q3 and Nine-Month FY2025 Results
Jan 27, 2026
Sumitomo Chemical India Ltd. has released its unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2025, following approval by its Board of Directors. The disclosure, made in compliance with SEB...
Sumitomo Chemical India Files Clean Q3 FY2025 Integrated Financial Results
Jan 27, 2026
Sumitomo Chemical India Ltd. has submitted its integrated financial filing for the quarter and nine months ended 31 December 2025, in line with SEBI’s revised disclosure framework and recent circulars from BSE and NSE. The company has releas...
Sumitomo Chemical India Reports Insider Trading Code Violation, Fines Senior Executive
Jan 2, 2026
Sumitomo Chemical India Limited has reported to the BSE and NSE a violation of its Code of Conduct under SEBI’s Prohibition of Insider Trading Regulations by a designated person. The company disclosed that Kaushal Shah, General Manager of it...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 19, 2025